163 related articles for article (PubMed ID: 32952557)
1. Comparison of Involved Field Radiotherapy versus Elective Nodal Irradiation in Stage IIIB/C Non-Small-Cell Lung Carcinoma Patients Treated with Concurrent Chemoradiotherapy: A Propensity Score Matching Study.
Topkan E; Ozdemir Y; Guler OC; Kucuk A; Besen AA; Mertsoylu H; Sezen D; Akdemir EY; Sezer A; Bolukbasi Y; Pehlivan B; Selek U
J Oncol; 2020; 2020():7083149. PubMed ID: 32952557
[TBL] [Abstract][Full Text] [Related]
2. Involved-field radiotherapy (IFRT) versus elective nodal irradiation (ENI) in combination with concurrent chemotherapy for 239 esophageal cancers: a single institutional retrospective study.
Yamashita H; Takenaka R; Omori M; Imae T; Okuma K; Ohtomo K; Nakagawa K
Radiat Oncol; 2015 Aug; 10():171. PubMed ID: 26269033
[TBL] [Abstract][Full Text] [Related]
3. Elective nodal irradiation (ENI) vs. involved field radiotherapy (IFRT) for locally advanced non-small cell lung cancer (NSCLC): A comparative analysis of toxicities and clinical outcomes.
Fernandes AT; Shen J; Finlay J; Mitra N; Evans T; Stevenson J; Langer C; Lin L; Hahn S; Glatstein E; Rengan R
Radiother Oncol; 2010 May; 95(2):178-84. PubMed ID: 20356642
[TBL] [Abstract][Full Text] [Related]
4. Elective nodal irradiation versus involved-field irradiation for stage II-IV cervical esophageal squamous cell carcinoma patients undergoing definitive concurrent chemoradiotherapy: a retrospective propensity study with 8-year survival outcomes.
Wang J; Wu Y; Zhang W; Chen Y; Liu Q; Jing S; Zhang J; Wu F; Wang J; Qiao X
Radiat Oncol; 2023 Aug; 18(1):142. PubMed ID: 37641149
[TBL] [Abstract][Full Text] [Related]
5. Involved field radiotherapy (IFRT) versus elective nodal irradiation (ENI) for locally advanced non-small cell lung cancer: a meta-analysis of incidence of elective nodal failure (ENF).
Li R; Yu L; Lin S; Wang L; Dong X; Yu L; Li W; Li B
Radiat Oncol; 2016 Sep; 11(1):124. PubMed ID: 27655339
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Toxicity Between Intensity-Modulated Radiotherapy and 3-Dimensional Conformal Radiotherapy for Locally Advanced Non-small-cell Lung Cancer.
Ling DC; Hess CB; Chen AM; Daly ME
Clin Lung Cancer; 2016 Jan; 17(1):18-23. PubMed ID: 26303127
[TBL] [Abstract][Full Text] [Related]
7. ＜Editors' Choice＞ Elective nodal irradiation versus involved field radiotherapy for limited disease small cell lung cancer: a single-institution experience.
Suzuki G; Yamazaki H; Aibe N; Masui K; Shimizu D; Kimoto T; Nagasawa S; Takenaka T; Masai N; Watanabe S; Seri S; Tamaki N; Takayama K; Yamada K
Nagoya J Med Sci; 2022 May; 84(2):327-338. PubMed ID: 35967948
[TBL] [Abstract][Full Text] [Related]
8. Intensity-modulated proton therapy for elective nodal irradiation and involved-field radiation in the definitive treatment of locally advanced non-small-cell lung cancer: a dosimetric study.
Kesarwala AH; Ko CJ; Ning H; Xanthopoulos E; Haglund KE; O'Meara WP; Simone CB; Rengan R
Clin Lung Cancer; 2015 May; 16(3):237-44. PubMed ID: 25604729
[TBL] [Abstract][Full Text] [Related]
9. A randomized study of involved-field irradiation versus elective nodal irradiation in combination with concurrent chemotherapy for inoperable stage III nonsmall cell lung cancer.
Yuan S; Sun X; Li M; Yu J; Ren R; Yu Y; Li J; Liu X; Wang R; Li B; Kong L; Yin Y
Am J Clin Oncol; 2007 Jun; 30(3):239-44. PubMed ID: 17551299
[TBL] [Abstract][Full Text] [Related]
10. [Clinical outcomes of different irradiation ranges in definitive intensity-modulated radiotherapy for esophageal cancer].
Zhu SC; Li QF; Zhang XY; Deng WZ; Song CY; Wang X; Yan K
Zhonghua Zhong Liu Za Zhi; 2020 Dec; 42(12):1040-1047. PubMed ID: 33342161
[No Abstract] [Full Text] [Related]
11. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation.
Grills IS; Yan D; Martinez AA; Vicini FA; Wong JW; Kestin LL
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):875-90. PubMed ID: 14529795
[TBL] [Abstract][Full Text] [Related]
12. Elective nodal irradiation or involved-field irradiation in definitive chemoradiotherapy for esophageal squamous cell cancer: a retrospective analysis in clinical N0 patients.
Sun Y; Zhang XL; Mao QF; Liu YH; Kong L; Li MH
Curr Oncol; 2018 Oct; 25(5):e423-e429. PubMed ID: 30464693
[TBL] [Abstract][Full Text] [Related]
13. Comparison of involved field radiotherapy and elective nodal irradiation in combination with concurrent chemotherapy for T1bN0M0 esophageal cancer.
Nakatani Y; Kato K; Shoji H; Iwasa S; Honma Y; Takashima A; Ushijima T; Ito Y; Itami J; Boku N
Int J Clin Oncol; 2020 Jun; 25(6):1098-1104. PubMed ID: 32189155
[TBL] [Abstract][Full Text] [Related]
14. Improved local control without elective nodal radiotherapy in patients with unresectable NSCLC treated by 3D-CRT.
Yang K; Cao F; Wang J; Liu L; Zhang T; Wu G
Front Med China; 2007 Oct; 1(4):381-5. PubMed ID: 24573930
[TBL] [Abstract][Full Text] [Related]
15. Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma.
Hsu FM; Lee JM; Huang PM; Lin CC; Hsu CH; Tsai YC; Lee YC; Chia-Hsien Cheng J
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e593-9. PubMed ID: 21658851
[TBL] [Abstract][Full Text] [Related]
16. Comparison between the effects of elective nodal irradiation and involved-field irradiation on long-term survival in thoracic esophageal squamous cell carcinoma patients: A prospective, multicenter, randomized, controlled study in China.
Lyu J; Yisikandaer A; Li T; Zhang X; Wang X; Tian Z; Chen L; Lu B; Chen H; Yang J; Wang Q; Zhang J; Ma Y; Liu R; Liu R; Hage A; Lang J
Cancer Med; 2020 Oct; 9(20):7460-7468. PubMed ID: 32841543
[TBL] [Abstract][Full Text] [Related]
17. Results of a preliminary study using hypofractionated involved-field radiation therapy and concurrent carboplatin/paclitaxel in the treatment of locally advanced non-small-cell lung cancer.
Matsuura K; Kimura T; Kashiwado K; Fujita K; Akagi Y; Yuki S; Murakami Y; Wadasaki K; Monzen Y; Ito A; Kagemoto M; Mori M; Ito K; Nagata Y
Int J Clin Oncol; 2009 Oct; 14(5):408-15. PubMed ID: 19856048
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of concurrent chemoradiotherapy with elective nodal irradiation for inoperable esophageal cancer.
Jing Z; Chen T; Zhang X; Wu S
Cancer Sci; 2017 Sep; 108(9):1828-1833. PubMed ID: 28665042
[TBL] [Abstract][Full Text] [Related]
19. Elective nodal irradiation provides a superior therapeutic modality for lymph node positivity esophageal squamous cell carcinoma patients receiving definitive radiotherapy versus involved-field irradiation.
Li Q; Zhu S; Li S; Deng W
Medicine (Baltimore); 2019 Jan; 98(3):e14080. PubMed ID: 30653123
[TBL] [Abstract][Full Text] [Related]
20. The role of involved field irradiation versus elective nodal irradiation in definitive radiotherapy or chemoradiotherapy for esophageal cancer- a systematic review and meta-analysis.
Wang H; Song C; Zhao X; Deng W; Shen W
Front Oncol; 2022; 12():1034656. PubMed ID: 36408184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
